ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
The results of trials of activity of esomeprazol in children with gastroesophagial reflux disease (gerd) are presented in this article. It was marked that esomeprazol (Nexium) can be used in children of 1–11 years (10 or 20 mg daily) and 12–17 years (20 or 40 mg daily) with gerd according to modern...
主要作者: | R.T. Saygitov |
---|---|
格式: | Article |
語言: | English |
出版: |
"Paediatrician" Publishers LLC
2008-08-01
|
叢編: | Вопросы современной педиатрии |
在線閱讀: | https://vsp.spr-journal.ru/jour/article/view/1441 |
相似書籍
-
ESOMEPRAZOL IN TREATMENT OF GASTROESOPHAGIAL REFLUX DISEASE IN CHILDREN AND ADOLESCENTS
由: R.T. Saygitov
出版: (2008-01-01) -
Clinical utility of esomeprazole for treatment of gastroesophageal reflux disease in pediatric and adolescent patients
由: Cardile S, et al.
出版: (2012-02-01) -
Efficacy of esomeprazole at treatment of patients with gastroesophageal reflux disease
由: Yu. V. Yevsyutina
出版: (2018-08-01) -
Effects of esomeprazole treatment for gastroesophageal reflux disease on quality of life in 12- to 17-year-old adolescents: an international health outcomes study
由: Gold Benjamin D, et al.
出版: (2009-11-01) -
Relationship between esomeprazole dose and timing to heartburn resolution in selected patients with gastroesophageal reflux disease
由: Roy C Orlando, et al.
出版: (2010-09-01)